Federal Policy
Latest
- Federal Policy
Bipartisan Bill Would Make PACE a Mandatory Medicaid Service
Reps. Debbie Dingell (D-Mich.) and John Moolenaar (R-Mich.) introduced the PACE Access Improvement Act on Sept. 24, which would make the Program of All-Inclusive Care for the Elderly a mandatory Medicaid service rather than a state option. The bill also aims to ease requirements so PACE providers can expand in-home care access. States currently choose whether to offer PACE, which serves frail, dual-eligible seniors who qualify for nursing home care but wish to remain in the community. If enacted, the measure would require all state Medicaid programs to cover PACE, likely spurring growth in the number of PACE organizations and enrollees nationwide.
- Federal Policy · MT
CMS Awards $8.7 Million for Rural Montana Ambulance Upgrades
CMS announced $8.7 million in federal funding to purchase new ambulances and medical equipment for rural emergency medical service providers across Montana. The funding is intended to help rural communities replace aging equipment and improve emergency response capacity. Federal officials framed the award as part of a broader push to support rural health infrastructure. Specific implementation timelines and grant recipient details were not detailed in the announcement.
- Federal Policy
States Face Deadline to Join Medicaid International Drug Pricing Pilot
In its D.C. Diagnosis newsletter, STAT reports that Wednesday is the deadline for states to opt into GENEROUS, a pilot program letting Medicaid access drugs at prices available abroad. Separately, the Senate health committee will vote Wednesday on three HHS nominees, but not on Heidi Overton, the nominee to lead the FDA, whose confirmation now won't be decided until after the Senate returns Nov. 9. CMS Administrator Mehmet Oz is also traveling to Texas to promote CHOICE arrangements, which let employers give workers tax-free funds to buy ACA Marketplace coverage.
- Federal Policy
CMS Ends Automatic Medicare Add-On Payments for Breakthrough Devices
CMS has finalized removal of the pathway that let FDA "breakthrough"-designated devices automatically qualify for supplemental Medicare payments, including new technology add-on payments and transitional pass-through payments, without demonstrating substantial clinical improvement or novelty. Device manufacturers are affected most directly, since new breakthrough-designated products will need to meet standard evidentiary requirements to secure extra payment starting in October. The change follows an August CMS rule finalizing the policy shift. While this is a Medicare payment policy change, Medicaid stakeholders should track it because device coverage and payment precedents set in Medicare often influence state Medicaid fee schedules and managed care benefit design for the same technologies.
- Federal Policy
Medicaid Work Requirements Set to Begin in 2027, CBO Projects Coverage Losses
New federally mandated Medicaid work requirements are scheduled to take effect at the start of 2027, and the nonpartisan Congressional Budget Office estimates the changes could leave 8 million more people nationally without health insurance. Patients and caregivers are voicing concern about how the requirements will affect their coverage and access to care. NBC News reports on these concerns ahead of implementation. State Medicaid agencies and beneficiaries have roughly a year to prepare for eligibility verification and enrollment changes.
- Federal Policy
Trump Administration Plans to Reshore Production of 86 Key Drugs
According to a Sept. 25 Bloomberg report cited by Becker's Hospital Review, the Trump administration is developing an initiative to move manufacturing of 86 essential medicines to the U.S. within 18 months. Under the plan, the Office of Management and Budget would solicit proposals from healthcare industry stakeholders on how to reshore production of drugs on the list. The report does not specify an effective date or regulatory vehicle for the initiative. Because many of the listed medicines are generics commonly used in Medicaid populations, supply chain shifts could affect drug availability and pricing that state Medicaid pharmacy programs and MCOs manage.
- Federal Policy
CMS Cancels 760,000 ACA Enrollments, Halts New Broker Sign-Ups
CMS cancelled roughly 760,000 individual Affordable Care Act Marketplace enrollments and imposed a temporary moratorium on registering new agents and brokers for plan year 2027, effective September 22, 2026. The action accompanies enhanced verification requirements aimed at curbing improper or unauthorized enrollments in ACA plans. Agents, brokers, health plans, and affected consumers must adjust to stricter oversight and potential enrollment disruptions during the moratorium period. Morgan Lewis reports the moves signal a broader shift toward more aggressive CMS scrutiny of Marketplace enrollment integrity.
- Federal Policy
Study Finds Sudden Infant Death Widening Black-White Mortality Gap
A study published Sept. 22 in JAMA Network Open found that the gap in infant mortality rates between Black and white babies widened between 2020 and 2024, with sudden unexpected infant death identified as the largest single driver of the disparity. Researchers analyzed federal birth and infant death records covering nearly 58 million live births to reach these findings. The study does not describe a specific policy action or regulatory change tied to the findings. For Medicaid programs, which finance a large share of births and infant care, the research underscores persistent racial disparities in birth outcomes relevant to maternal and infant health initiatives.
- Federal Policy
Senate Democrats Question Kennedy Ethics Compliance on Vaccine Lawsuit Divestment
Senate Democrats are questioning whether HHS Secretary Robert F. Kennedy Jr. potentially violated his ethics agreement by allegedly concealing an arrangement to collect money from a settlement with a vaccine manufacturer. Kennedy pledged to divest from the lawsuit during his confirmation process last year. The senators' inquiry raises concerns about potential conflicts of interest at the federal agency overseeing Medicaid and other health programs. The matter is significant for Medicaid stakeholders because Kennedy's leadership of HHS includes oversight of CMS, which administers the Medicaid program and sets immunization policy affecting coverage requirements for state programs and managed care plans.

- Federal Policy
CMS Proposes Reduced Payment for Same-Day Evaluation and Procedure Services
CMS has proposed a rule to reduce Medicare payment for evaluation and management services performed on the same day as a procedure, paying full price for the more expensive service and a reduced rate for the second to account for shared costs. The change would affect how providers bill Medicare Part B for same-day services, such as when a dermatologist evaluates a patient and immediately performs a removal procedure during the same visit. The proposal aims to eliminate duplicative billing and reduce out-of-pocket costs for Medicare beneficiaries, who currently pay copayments based on the full rate for both services. The rule would lower costs for patients and taxpayers by preventing Medicare from paying twice for overlapping service components.

- Federal Policy
SAMHSA Awards $247.9 Million in Behavioral Health Grants
The Substance Abuse and Mental Health Services Administration announced September 25 that it awarded $247.9 million in grants to expand access to addiction treatment, mental health services, and recovery support. The funds will support school-based mental health services, trauma treatment for children and families, overdose reversal efforts by first responders and communities, and employment support for people in recovery. The awards take effect immediately for grantees nationwide. For state Medicaid agencies and managed care organizations, these federal grants represent new resources that may complement or coordinate with Medicaid-funded behavioral health services, particularly for populations eligible for both programs.
- Federal Policy
CMS Strengthens Federal ACA Marketplace Anti-Fraud Efforts
In its Health Care Week in Review, Alston & Bird reports that CMS has strengthened anti-fraud efforts for the federal ACA marketplace. The changes affect health plans participating in the federal exchange and brokers or agents facilitating enrollment. The timing and specific measures were not detailed in the available summary. The action reflects CMS's continued focus on program integrity in marketplace operations, with potential compliance implications for participating insurers and enrollment entities.
- Federal Policy · TX
CMS Awards $51 Million for Rural Texas Nutrition and Chronic Disease Prevention Programs
CMS announced a $51 million federal funding award for nutrition and chronic disease prevention programs targeting rural Texas communities. The award aims to address health disparities in rural areas through improved access to nutrition services and chronic disease management. The programs will affect Medicaid beneficiaries in rural Texas counties through expanded community-based health interventions. This funding matters for state Medicaid agencies and managed care organizations operating in rural Texas markets, as it may create new care coordination requirements and community partnership opportunities to address preventable chronic conditions among Medicaid populations.
- Federal Policy
CMS Launches Quality Partnership With 37 States to Shift Medicaid Measures Toward Health Outcomes
CMS announced a new quality measurement partnership with 37 states to refocus Medicaid quality metrics on health outcomes rather than process measures. The initiative launches immediately and will develop and test outcome-based measures over the next 18 to 24 months. The shift affects how state Medicaid agencies and managed care plans will be evaluated for quality performance, requiring changes to quality strategies, managed care contracts, and potentially capitation rate methodologies. States participating in the partnership will pilot new outcome measures before broader adoption across the Medicaid program.
- Federal Policy
Census Bureau Proposes Eliminating Race and Ethnicity Data Collection
In September 2026, the Census Bureau issued a proposed rule that would prohibit the collection of race and ethnicity data in the decennial census and exclude many noncitizen immigrants from the apportionment count. The changes would affect how Medicaid programs identify disparities in access, quality, and outcomes for beneficiaries. If finalized, the rule would limit state Medicaid agencies' and managed care organizations' ability to stratify performance data, target interventions, and comply with federal health equity reporting requirements that rely on census-based demographic benchmarks. The proposed changes matter because Medicaid programs use census race and ethnicity data to establish stratified quality measures, identify underserved populations for outreach and enrollment, and allocate resources for programs addressing maternal health, behavioral health, and chronic disease disparities.
- Federal Policy
New Customs Requirements Set to Disrupt Canadian Prescription Imports October 22
The Wall Street Journal reports that new customs requirements taking effect October 22, 2026, could disrupt access to prescription drugs for millions of Americans who purchase medications from Canadian and other foreign mail-order pharmacies. The change affects individuals who rely on imported pharmaceuticals for cost savings. The timing and scope of enforcement will determine how many consumers and which medication categories face immediate supply interruptions. For Medicaid programs, this could increase formulary pressure if beneficiaries who previously self-paid for imported drugs now seek coverage through state plans, and may affect dual-eligible populations managing Medicare Part D coverage gaps.
- Federal Policy
AHA Urges Permanent Ban on 340B Rebate Models in SECURE 340B Act Comments
The American Hospital Association submitted comments on September 23 supporting the bipartisan SECURE 340B Act introduced in July, urging Congress to permanently prohibit rebate models in the 340B drug pricing program. The legislation combines hospital-sought protections with new program requirements. AHA stated it shares the bill's goals while seeking the rebate ban provision. This affects how safety-net hospitals and Medicaid providers access discounted pharmaceuticals under 340B, with potential implications for pharmacy carve-outs and drug purchasing arrangements in Medicaid managed care.
- Federal Policy
NAMD Submits Comments on CMS Medicaid Enterprise Systems IT Standards RFI
The National Association of Medicaid Directors submitted comments to CMS in response to a request for information on Medicaid Enterprise Systems IT standards. The RFI solicited stakeholder input on technical standards and interoperability requirements for state Medicaid IT systems. State Medicaid agencies are directly affected as these standards will shape future MES certification requirements and enhanced federal funding eligibility. The timing matters because CMS is gathering input to inform future rulemaking on MES modernization and MITA framework requirements.
- Federal Policy
CMS Issues Federal Funding Methodology for Basic Health Program Year 2027
CMS released an informational bulletin outlining the federal funding methodology for the Basic Health Program (BHP) in program year 2027. The guidance details how CMS will calculate federal payments to states operating BHPs — currently Minnesota and New York — for coverage of low-income individuals ineligible for Medicaid but below 200% of the federal poverty level. The methodology takes effect for the program year beginning in 2027. This matters for the two BHP states because the federal payment formula directly determines their program budgets and affects whether BHP remains financially sustainable compared to Marketplace coverage.
- Federal Policy
CMS Seeks Comment on Generic Clearance for State Plan Amendments and Waiver Information Collections
CMS has published a Federal Register notice requesting public comment on one or more information collection requests under its existing Paperwork Reduction Act generic clearance umbrella (control number 0938-1148). The umbrella, approved in April 2021, covers Medicaid and CHIP state plan amendments, waivers, demonstrations, and reporting requirements. Comments are due 60 days from publication. The generic clearance process allows CMS to expedite approval of voluntary, low-burden information collections that do not raise substantive policy issues, streamlining the agency's ability to request information from states without full PRA review for each individual collection.